Eligibility Criteria for Publicly-Funded Vaccines

Revised October 1, 2007

Diphtheria, pertussis (whooping cough), tetanus (lockjaw), haemophilus type b, botulism and diphtheria antitoxins; various immune globulins; measles, mumps, rubella; polio (inactivated).

Eligibility criteria for these vaccines are found in The Canadian Immunization Guide (2006).

• children <5 years who are household contacts of acute cases and significant exposures as described in the Manitoba Health PEP Protocol.

• grade nine students (14-16 yrs. administered by Public Health Nurses in schools), individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program, children > 4 yrs with an incomplete primary series

• clotting factor deficiencies, pediatric bone marrow transplants, contacts of Hepatitis A cases and persons in communities with a confirmed Hepatitis A outbreak (as determined by local Medical Officer of Health (Public Health)).

• grade four students (administered by Public Health Nurses in schools), infants born to infected/suspected infected mothers, sexual/household/needle or razor sharing contacts of acute & chronic cases of Hepatitis B, persons with multiple sexual partners or a recent history of an STI, dialysis patients, frequent recipients of blood products, persons with a significant exposure as described in the Manitoba Health Post Exposure Protocol, individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program, persons with Hepatitis C or chronic liver disease, offenders and new admissions to institutions for the developmentally challenged.

• men who have sex with men (MSM) or who are bisexual, intravenous drug users (IVDU), individuals with hepatitis C (HCV) or chronic liver disease and street-involved

• individuals at high-risk for influenza related complications: e.g.: adults & children (≥ 6 months of age) with chronic cardiac or pulmonary disorders, residents of personal care homes, healthy children 6-23 months, persons ≥ 65 years of age, pregnant women
• Adults and children who have any condition that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk of aspiration.
• persons with diabetes mellitus and other metabolic diseases, cancer, immunodeficiency, immunosuppression (due to treatment or underlying disease), renal disease, anemia, hemoglobinopathy
• children and adolescents (6 mo. to 18 yrs) treated for long periods with acetylsalicylic acid
• individuals capable of transmitting the flu to those at high risk eg. health care workers, first responders, household contacts of children 0-23 months, and household contacts of people ≥ 65 years of age

• Grade 4 students born on or after January 1, 1995. This group will be offered the meningococcal conjugate C vaccine in schools by Public Health Nurses.
• individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program
• contact(s) of meningococcal serogroup C case (approved by Public Health)

• persons with terminal/alternative complement deficiencies
• functional/anatomic asplenia (may include sickle cell anemia, thalassemia major, essential thrombocytopenia, celiac disease and inflammatory bowel disease, etc.)

• Children <5 yrs. of age with one or more of:  functional or anatomic asplenia, immunosuppression/immunodeficiency, nephrotic syndrome,
• chronic cardiac disease, chronic pulmonary disease (excluding asthma not requiring high dose steroids), CSF leak, poorly controlled diabetes
• cochlear implant recipients, renal failure
• Children born on or after January 1, 2004
• individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program

 
• Immunodeficiency: splenic disorders (asplenia or hyposplenism, sickle cell anemia, thalassemia major, essential thrombocytopenia, celiac disease, inflammatory bowel disease), chronic liver and renal disease, congenital immunodeficiency conditions (antibody defects, complement deficiency), immunosuppressive therapy, hematopoietic stem cell & solid organ transplantation, impaired immune responsiveness e.g. HIV (see detailed condition description in The Canadian Immunization Guide.)
• persons > 65 years of age, residents of long term care facilities
• persons 2 to 64 years of age with chronic underlying illness including cardiac e.g. congestive heart failure, or pulmonary disease e.g. broncho-pulmonary dysplasia, diabetes mellitus, CSF leaks, cochlear implant recipients.

• persons with occupational or activity related risks: e.g.: taxidermists, trappers, spelunkers, working with injured wildlife, conservation officers, veterinarian assistants, animal control officers. Business/pleasure travellers to rabies endemic countries are not eligible.
• high-risk occupational related travel e.g. zoologists working in rabies endemic country.

• approval by Medical Officer of Health (Public Health)

• approval by Medical Officer of Health (Public Health)

• High-risk susceptible persons: as described in the The Canadian Immunization Guide (2006) with cystic fibrosis who are receiving long term acetylsalicylic acid therapy and who are immunocompromised
• Susceptible household contacts of such persons, whether the high-risk person can be safely immunized or not.
• Infants (12 months of age) born on or after January 1, 2004, susceptible children born on or after January 1, 1999 at the time of their preschool booster, susceptible grade 4 students. The Public Health Nurses will offer the varicella vaccine to grade 4 students in schools.
• individuals who are part-way through an immunization series started in another jurisdiction as part of a universal program

Communicable Disease Control (CDC) Branch Public Health Division Manitoba Health 4th Floor - 300 Carlton St. Winnipeg MB  R3B 3M9  CANADA Phone: (204) 788-6737 Fax: (204) 948-2040	See also:  Manitoba's Routine Childhood Immunization Schedule for Infants and Children.